• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Renovaro Inc. - Common Stock (NQ: RENB )

    1.250 -0.050 (-3.85%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 325,402
    Open 1.310
    Bid (Size) 1.210 (5)
    Ask (Size) 1.330 (1)
    Prev. Close 1.300
    Today's Range 1.190 - 1.340
    52wk Range 0.6601 - 5.250
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Renovaro, Inc. Announces $10 million in Equity Committed
    From Renovaro Inc
    Via GlobeNewswire

    Performance

    YTD
    -60.82%
    -60.82%
    1 Month
    -21.38%
    -21.38%
    3 Month
    -36.55%
    -36.55%
    6 Month
    -72.47%
    -72.47%
    1 Year
    +66.22%
    +66.22%

    More News

    Read More
    Impressive Short Squeeze Triggered for Cancer Immunotherapy Company Renovaro, Inc. (NASDAQ: RENB)
    Via Get News
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
    From Renovaro Inc
    Via GlobeNewswire
    Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
    Via FinancialNewsMedia
    Topics Death
    Exposures Death
    Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
    From FN Media Group LLC
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
    Via Benzinga
    RENB Stock Earnings: Renovaro Biosciences Reported Results for Q3 2024
    Via InvestorPlace
    Renovaro Inc. (NASDAQ: RENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection
    Via News Direct
    Topics Artificial Intelligence Death
    Exposures Artificial Intelligence Death
    Launch of Groundbreaking Cancer Detection Platform Flamingo with Nvidia AI Computing Power, Plus Plans to Acquire 100% Ownership of Cyclomics: Renovaro Inc. (Nasdaq: RENB)
    Via Get News
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
    From Renovaro Inc
    Via GlobeNewswire
    Trailblazing AI Driven Early Cancer Diagnostics and Therapeutics for Detection with Nvidia Super Computing Power; Acquiring 100% Ownership of Cyclomics; Renovaro Inc. (Nasdaq: RENB)
    Via Get News
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
    From Renovaro Inc
    Via GlobeNewswire
    Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient
    From Renovaro Biosciences Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
    Via NewMediaWire
    ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
    Via TheNewswire.com
    Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    ROSEN, A TOP RANKED LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Red Flag Alert: 3 Stocks That Hindenburg Research Is Shorting Now
    Via InvestorPlace
    RENOVARO ALERT: Bragar Eagel & Squire, P.C. is Investigating Renovaro Biosciences Inc. on Behalf of Renovaro Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.